Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium

Published:2023-12 Issue: Volume:31 Page:101111
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

David Marion,Monteferrario Davide,Saviane Gaëlle,Jeanneau Caroline,Marchetti Irène,Dupont Coralie F.,Dumont Céline,Fontenot Jason D.,Rosa Maurus de la,Fenard David^ORCID

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference38 articles.

1. Plasma Cell Biology;Lucas,2015

2. Long-Lived Plasma Cells in Mice and Men;Brynjolfsson;Front. Immunol.,2018

3. Immunotherapy perspectives in the new era of B-cell editing;Cahen;Blood Adv.,2021

4. Vector Strategies to Actualize B Cell-Based Gene Therapies;Jeske;J. Immunol.,2021

5. Genome edited B cells: a new frontier in immune cell therapies;Rogers;Mol. Ther.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP